Loading company details...
Beta
Latest Form 4 (Oct 8, 2026): Daniel J. Lippis (CVP, TAVR): Exercise/Conversion of 619 shares, $45.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2026 | Daniel J. Lippis, CVP, TAVR | Exercise/Conversion | 619 | $45.0K |
| Sep 14, 2026 | Wayne Markowitz, CVP, JAPAC | Tax Withholding | 355 | $30.8K |
| Sep 14, 2026 | Andrew M. Dahl, SVP, Corporate Controller | Tax Withholding | 253 | $21.3K |
| Sep 11, 2026 | Daveen Chopra, CVP, TMTT, Surgical & IHFM | Tax Withholding | 398 | $34.5K |
| Sep 11, 2026 | Daniel J. Lippis, CVP, TAVR | Exercise/Conversion | 619 | $45.0K |
| Aug 31, 2026 | Andrew M. Dahl, SVP, Corporate Controller | Sale | 544 | $49.5K |
| Aug 28, 2026 | Annette Bruls, CVP, EMEACLA | Sale | 2,644 | $237.9K |
| Aug 26, 2026 | Daveen Chopra, CVP, TMTT, Surgical & IHFM | Exercise/Conversion | 31,800 | $2.31M |
| Aug 26, 2026 | Wayne Markowitz, CVP, JAPAC | Sale | 1,240 | $113.4K |
| Aug 11, 2026 | Daniel J. Lippis, CVP, TAVR | Exercise/Conversion | 619 | $45.0K |